SPDR S&P Telecom ETF(XTL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

XTL SPDR S&P Telecom ETF

Closed 04-15 16:00:00 EDT

211.13

+2.01

+0.96%

盘后211.13

+0.000.00%

19:53 EDT

High211.13	Low207.00	Vol122.60K
Open209.89	D1 Closing209.12	Amplitude1.97%
Mkt Cap596.44M	Tradable Cap596.44M	Total Shares2.83M
T/O25.70M	T/O Rate4.34%	Tradable Shares2.83M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"XTL","market":"US","secType":"STK","nameCN":"SPDR S&P Telecom ETF","latestPrice":211.13,"timestamp":1776283200000,"preClose":209.12,"halted":0,"volume":122597,"hourTrading":{"tag":"盘后","latestPrice":211.13,"preClose":211.13,"latestTime":"19:53 EDT","volume":261,"amount":55509.4668,"timestamp":1776297235496,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00961170619739858,"floatShares":2825000,"shares":2825000,"eps":0,"marketStatus":"Closed","change":2.01,"latestTime":"04-15 16:00:00 EDT","open":209.89,"high":211.13,"low":207,"amount":25698987.876989998,"amplitude":0.019749,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776326400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":209.12,"sharesOutstanding":1625000,"nav":209.162027,"aum":622257031.295,"dividendRate":0.009405,"bidAskSpread":0.001424,"preHourTrading":{"tag":"盘前","latestPrice":210,"preClose":209.12,"latestTime":"08:53 EDT","volume":14,"amount":2940,"timestamp":1776257610051,"change":0.88,"changeRate":0.004208,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":211.13,"preClose":211.13,"latestTime":"19:53 EDT","volume":261,"amount":55509.4668,"timestamp":1776297235496,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.843672,"impliedVol":0.2914,"impliedVolPercentile":0.864},"requestUrl":"/m/hq/s/XTL/wiki","defaultTab":"wiki","newsList":[{"id":"2622701498","title":"XTL Biopharmaceuticals trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2622701498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622701498?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:50","pubTimestamp":1774396233,"startTime":"0","endTime":"0","summary":"19:50 EDT XTL Biopharmaceuticals (XTLB) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTL","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621751741","title":"XTL Biopharmaceuticals to Change ADS Ratio","url":"https://stock-news.laohu8.com/highlight/detail?id=2621751741","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621751741?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:34","pubTimestamp":1774038844,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals (XTLB) said late Friday it plans to change the ratio of its American Depositary Shares to 1 ADS to 400 shares from 1 ADS to 100 shares, effective March 25.The ratio change will have the same effect as a 1-for-4 reverse ADS split for its ADS holders, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XTLB","XTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621754885","title":"XTL Biopharmaceuticals to Implement One-for-Four ADS Reverse Split Effective March 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2621754885","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621754885?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:27","pubTimestamp":1774038440,"startTime":"0","endTime":"0","summary":"The latest update is out from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ). On March 20, 2026, XTL Biopharmaceuticals announced it will change ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-implement-one-for-four-ads-reverse-split-effective-march-25-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-to-implement-one-for-four-ads-reverse-split-effective-march-25-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTLB","XTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618937396","title":"Beyond Air announces termination of NeuroNOS agreement with XTL","url":"https://stock-news.laohu8.com/highlight/detail?id=2618937396","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618937396?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:35","pubTimestamp":1773142543,"startTime":"0","endTime":"0","summary":"Beyond Air (XAIR) announced that the previously disclosed proposed transaction with XTL Biopharmaceuticals (XTLB) relating to Beyond Air’s NeuroNOS...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beyond-air-announces-termination-of-neuronos-agreement-with-xtl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beyond-air-announces-termination-of-neuronos-agreement-with-xtl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","XTLB","BK4082","XAIR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614827898","title":"XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination","url":"https://stock-news.laohu8.com/highlight/detail?id=2614827898","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614827898?lang=en_us&edition=fundamental","pubTime":"2026-02-28 06:00","pubTimestamp":1772229653,"startTime":"0","endTime":"0","summary":"An update from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) is now available. On February 27, 2026, XTL Biopharmaceuticals disclosed that Nasda...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-nasdaq-delisting-after-public-shell-determination?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-nasdaq-delisting-after-public-shell-determination?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XTLB","XTL","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614867286","title":"XTL Biopharmaceuticals gets delisting letter from Nasdaq, to request hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614867286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614867286?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:35","pubTimestamp":1772228158,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals (XTLB) announced that it has received a letter from Nasdaq, dated February 25, notifying the company of the staff’s belief, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-gets-delisting-letter-from-nasdaq-to-request-hearing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xtl-biopharmaceuticals-gets-delisting-letter-from-nasdaq-to-request-hearing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4139","XTL","XTLB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614677898","title":"XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing","url":"https://stock-news.laohu8.com/highlight/detail?id=2614677898","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614677898?lang=en_us&edition=fundamental","pubTime":"2026-02-28 05:30","pubTimestamp":1772227800,"startTime":"0","endTime":"0","summary":"RAMAT GAN, ISRAEL, Feb.  27, 2026  (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a letter (the “Letter”) f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/27/3246813/0/en/XTL-Announces-Receipt-of-Staff-Delist-Determination-from-Nasdaq-and-Plans-to-Request-Hearing.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4077","XTL","XTLB","SLE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606371755","title":"XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2606371755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606371755?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:17","pubTimestamp":1769609841,"startTime":"0","endTime":"0","summary":"The latest announcement is out from XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ). On January 28, 2026, XTL Biopharmaceuticals Ltd. announced it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-advances-neuronos-acquisition-and-plans-2-million-private-placement-to-address-nasdaq-equity-deficiency?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4588","BK4215","XTL","XTLB","EQR","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605612286","title":"XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2605612286","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605612286?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:11","pubTimestamp":1769206267,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) just unveiled an update. On January 23, 2026, XTL Biopharmaceuticals reported that its wholly owne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-faces-subsidiary-insolvency-filing-reviews-1-5-million-loan-exposure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTLB","BK4139","XTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605286646","title":"XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2605286646","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605286646?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:10","pubTimestamp":1769206256,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has provided an announcement. On January 23, 2026, XTL Biopharmaceuticals disclosed that it receiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-flags-nasdaq-equity-deficiency-given-deadline-to-regain-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTLB","XTL","BK4588","BK4215","EQR","BK4585","NQmain","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605285567","title":"XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2605285567","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605285567?lang=en_us&edition=fundamental","pubTime":"2026-01-24 05:10","pubTimestamp":1769202600,"startTime":"0","endTime":"0","summary":"RAMAT GAN, ISRAEL, Jan.  23, 2026  (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter fro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/23/3225065/0/en/XTL-Announces-Receipt-of-Nasdaq-Notification-Regarding-Minimum-Stockholders-Equity-Deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XTLB","BK4215","BK4588","BK4585","XTL","SLE","EQR","91348","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603865846","title":"ADRs Hold Steady; XTL Biopharmaceuticals Ltd. Climbs 57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603865846","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603865846?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:30","pubTimestamp":1768339800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed flat on Tuesday, as the S&P/BNY Mellon index of American depositary receipts was flat at 248.92.The European index added 0.1% to 219.06. The Asian index declined 0.1% to 333.23. The Latin American index rose 0.2% to 247.81, while the emerging-markets index dropped 0.3% to 557.38.Israel's XTL Biopharmaceuticals Ltd. was the biggest leader during the session, soaring 57% to $1.07, and China-based 111 Inc. rocketed 37% to $5.00. Immuron Ltd., which is based in Australia, rounded out the top three leaders on Tuesday, with shares rocketing 23% to $1.20.Zepp Health Corp., based in China, posted the largest decline, plunging 15% to $22.81, followed by shares of India's Sify Technologies Ltd., which plunged 14% to $12.94. Shares of China-based MOGU Inc. plunged 11% to $2.00.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XTLB","XTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603968077","title":"XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968077","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603968077?lang=en_us&edition=fundamental","pubTime":"2026-01-13 22:28","pubTimestamp":1768314480,"startTime":"0","endTime":"0","summary":"Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/13/3217924/0/en/XTL-Biopharmaceuticals-Acquires-85-of-NeuroNOS-Entering-the-Massive-Autism-Market-with-Nobel-Prize-Winning-Scientific-Leadership.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTL","BK4077","XTLB","BK4082","SLE","BK4139","XAIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603681455","title":"XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2603681455","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603681455?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:58","pubTimestamp":1768309114,"startTime":"0","endTime":"0","summary":"XTL Biopharmaceuticals Sponsored ADR ( ($XTLB) ) has shared an announcement. On January 13, 2026, XTL Biopharmaceuticals Ltd. signed a binding lett...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-moves-to-acquire-neuronos-stake-from-beyond-air-and-plans-2-million-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtl-biopharmaceuticals-moves-to-acquire-neuronos-stake-from-beyond-air-and-plans-2-million-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XTL","XTLB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2574191259","title":"ADRs Close Lower; XTL Biopharmaceuticals Ltd. Declines 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574191259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574191259?lang=en_us&edition=fundamental","pubTime":"2025-10-10 04:30","pubTimestamp":1760041800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed lower on Thursday, as the S&P/BNY Mellon index of American depositary receipts dropped 1.4% to 228.63.The European index dropped 1.2% to 197.51. The Asian index declined 1.6% to 315.00. The Latin American index dropped 0.3% to 211.89, while the emerging-markets index dropped 1.7% to 524.65.XTL Biopharmaceuticals Ltd., based in Israel, posted the largest decline, plunging 16% to $1.73, followed by shares of Israel's Scinai Immunotherapeutics Ltd., which dropped 9.2% to $1.48. Shares of United Kingdom-based Argo Blockchain PLC dropped 8.5% to 61 cents.China's Ambow Education Holding Ltd. was the biggest leader during the session, soaring 61% to $5.75, and China-based 9F Inc. soared 58% to $4.35. Biodexa Pharmaceuticals PLC, which is based in United Kingdom, rounded out the top three leaders on Thursday, with shares soaring 40% to $10.81.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTLB","XTL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://us.spdrs.com/en/product/fund.seam?ticker=XTL","stockEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":0.1332},{"period":"3month","weight":0.3037},{"period":"6month","weight":0.3969},{"period":"1year","weight":1.2574},{"period":"ytd","weight":0.3648}],"compareEarnings":[{"period":"1week","weight":0.0535},{"period":"1month","weight":0.0486},{"period":"3month","weight":0.0059},{"period":"6month","weight":0.0512},{"period":"1year","weight":0.2881},{"period":"ytd","weight":0.0184}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"In seeking to track the performance of the S&P Telecom Select Industry Index (the \"index\"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the telecommunications segment of the S&P Total Market Index (\"S&P TMI\").","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.012129},{"month":2,"riseRate":0.5625,"avgChangeRate":0.017738},{"month":3,"riseRate":0.375,"avgChangeRate":-0.008067},{"month":4,"riseRate":0.5,"avgChangeRate":-0.002884},{"month":5,"riseRate":0.733333,"avgChangeRate":0.010264},{"month":6,"riseRate":0.6,"avgChangeRate":0.012134},{"month":7,"riseRate":0.666667,"avgChangeRate":0.027862},{"month":8,"riseRate":0.533333,"avgChangeRate":0.010685},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020678},{"month":10,"riseRate":0.666667,"avgChangeRate":0.01893},{"month":11,"riseRate":0.733333,"avgChangeRate":0.027279},{"month":12,"riseRate":0.533333,"avgChangeRate":0.009135}],"exchange":"ARCA","name":"SPDR S&P Telecom ETF","nameEN":"SPDR S&P Telecom ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SPDR S&P Telecom ETF(XTL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SPDR S&P Telecom ETF(XTL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SPDR S&P Telecom ETF,XTL,SPDR S&P Telecom ETF股票,SPDR S&P Telecom ETF股票老虎,SPDR S&P Telecom ETF股票老虎国际,SPDR S&P Telecom ETF行情,SPDR S&P Telecom ETF股票行情,SPDR S&P Telecom ETF股价,SPDR S&P Telecom ETF股市,SPDR S&P Telecom ETF股票价格,SPDR S&P Telecom ETF股票交易,SPDR S&P Telecom ETF股票购买,SPDR S&P Telecom ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SPDR S&P Telecom ETF(XTL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SPDR S&P Telecom ETF(XTL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}